Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M96,815Revenue (TTM) $M23,777Net Margin (%)23.0Altman Z-Score2.3
Enterprise Value $M118,105EPS (TTM) $3.3Operating Margin %34.2Piotroski F-Score7
P/E(ttm)18.1Beneish M-Score-2.1Pre-tax Margin (%)29.6Higher ROA y-yY
Price/Book20.810-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %--Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow13.0y-y EBITDA Growth Rate %132ROA % (ttm)11.3Higher Current Ratio y-yY
Dividend Yield %3.6PEG--ROE % (ttm)135Less Shares Outstanding y-yN
Payout Ratio %63.0Shares Outstanding M1,617ROIC % (ttm)26.4Gross Margin Increase y-yY

Gurus Latest Trades with ABBV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABBVJoel Greenblatt 2016-03-31 Add0.28%$51.18 - $59.24
($55.77)
$ 59.867%Add 216.32%645,835
ABBVJohn Paulson 2016-03-31 Sold Out -0.05%$51.18 - $59.24
($55.77)
$ 59.867%Sold Out0
ABBVDavid Dreman 2016-03-31 Add0.03%$51.18 - $59.24
($55.77)
$ 59.867%Add 16.28%30,542
ABBVNWQ Managers 2016-03-31 Add0.02%$51.18 - $59.24
($55.77)
$ 59.867%Add 3.64%781,850
ABBVKen Fisher 2016-03-31 Reduce-0.02%$51.18 - $59.24
($55.77)
$ 59.867%Reduce -20.51%743,284
ABBVDodge & Cox 2016-03-31 Reduce$51.18 - $59.24
($55.77)
$ 59.867%Reduce -0.07%33,232
ABBVMario Gabelli 2016-03-31 Reduce$51.18 - $59.24
($55.77)
$ 59.867%Reduce -12.66%35,460
ABBVNWQ Managers 2015-12-31 Reduce-0.65%$48.27 - $64.13
($57.69)
$ 59.864%Reduce -50.59%754,413
ABBVFirst Eagle Investment 2015-12-31 Sold Out -0.14%$48.27 - $64.13
($57.69)
$ 59.864%Sold Out0
ABBVJoel Greenblatt 2015-12-31 Add0.08%$48.27 - $64.13
($57.69)
$ 59.864%Add 179.54%204,171
ABBVJohn Paulson 2015-12-31 Buy 0.05%$48.27 - $64.13
($57.69)
$ 59.864%New holding139,700
ABBVDavid Dreman 2015-12-31 Reduce-0.03%$48.27 - $64.13
($57.69)
$ 59.864%Reduce -15.80%26,267
ABBVMario Gabelli 2015-12-31 Reduce$48.27 - $64.13
($57.69)
$ 59.864%Reduce -7.58%40,600
ABBVKen Fisher 2015-12-31 Add$48.27 - $64.13
($57.64)
$ 59.864%Add 0.77%935,104
ABBVFirst Eagle Investment 2015-09-30 Add0.05%$52.5 - $71.23
($65.09)
$ 59.86-8%Add 55.71%1,056,150
ABBVDavid Dreman 2015-09-30 Add0.02%$52.5 - $71.23
($65.09)
$ 59.86-8%Add 10.27%31,197
ABBVJoel Greenblatt 2015-09-30 Add0.02%$52.5 - $71.23
($65.09)
$ 59.86-8%Add 117.34%73,037
ABBVKen Fisher 2015-09-30 Reduce-0.01%$52.5 - $71.23
($65.09)
$ 59.86-8%Reduce -7.82%927,959
ABBVMario Gabelli 2015-09-30 Reduce$52.5 - $71.23
($65.09)
$ 59.86-8%Reduce -5.65%43,930
ABBVDodge & Cox 2015-09-30 Reduce$52.5 - $71.23
($65.09)
$ 59.86-8%Reduce -2.92%33,255
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABBV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABBV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GONZALEZ RICHARD AChairman of the Board and CEO 2016-06-02Sell285,953$63.82-6.2view
GONZALEZ RICHARD AChairman of the Board and CEO 2016-05-11Sell39,000$63.8-6.18view
HURWICH THOMAS A.VP, Controller 2016-05-10Sell6,000$63.59-5.87view
RICHMOND TIMOTHY J.SVP, Human Resources 2016-05-10Sell21,583$63.52-5.76view
ALBAN CARLOSEVP, Commercial Operations 2016-05-10Sell47,438$63.52-5.76view
Schumacher Laura JExecutive Vice President 2016-03-08Sell25,000$56.096.72view
RICHMOND TIMOTHY J.SVP, Human Resources 2016-03-01Sell12,866$55.058.74view
SALEKI-GERHARDT AZITASVP, Operations 2016-02-29Sell1,776$55.388.09view
HURWICH THOMAS A.VP, Controller 2016-02-29Sell1,444$55.258.34view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-07-29Sell40,021$71.24-15.97view

Press Releases about ABBV :

Quarterly/Annual Reports about ABBV:

News about ABBV:

Articles On GuruFocus.com
5 Attractive Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016 
Weekly CEO Sells Highlight Jun 06 2016 
Wall Street Estimates and Biopharma Value Investing Jun 02 2016 
Dividend and Value Opportunities in the Large-Cap Pharmaceutical Space Apr 05 2016 
A Cheap Dividend Aristocrat Yielding Over 4% Mar 02 2016 
John Paulson Bulks Up Health Care Bet Feb 17 2016 
Gilead, Johnson & Johnson or Roche? Feb 11 2016 
Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015 
Health Care Investor Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015 
Merck & Co. Versus AbbVie: Who Is the Winner and Who Is the Loser? Nov 12 2015 

More From Other Websites
2 Key FDA Actions On Potential Blockbuster Drugs Next Week Jun 24 2016
AbbVie, Inc. : ABBV-US: Dividend Analysis : July 15th, 2016 (record date) : By the numbers : June... Jun 24 2016
CORRECTED (OFFICIAL)-Novartis aims to nearly triple biosimilar drugs on market by 2020 Jun 20 2016
AbbVie Teams Up with Leading Nonprofit Organizations to Give Back to Underserved Local Communities Jun 20 2016
Novartis aims to nearly triple biosimilar drugs on market by 2020 Jun 19 2016
6 Companies That Destroyed Shareholders Last Week Jun 19 2016
AbbVie Declares Quarterly Dividend Jun 16 2016
AbbVie Declares Quarterly Dividend Jun 16 2016
AbbVie Scholarship Programs Recognize Exceptional Students Living with Chronic Inflammatory Diseases Jun 16 2016
[$$] Infinity Pharmaceuticals' Disappointing Data Jun 16 2016
One Reason Why AbbVie (ABBV) Stock Closed Up Today Jun 15 2016
Infinity Pharmaceuticals Faces Downgrades as Drug Results Disappoint Jun 15 2016
AbbVie: Low Expectations, Cheap Valuation, What's Not to Love? Jun 15 2016
6 Biopharma Movers Making a Run on Wednesday Jun 15 2016
Infinity (INFI) at 52-Week Low on Disappointing Duvelisib Data Jun 15 2016
Why Infinity Pharmaceuticals Crashed Jun 14 2016
Agios Upgraded As Anemia Drug Data Soothes Safety Concerns Jun 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)